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Introduction
Erythromelalgia (EM) (erythro ϭ red; melos ϭ limb; algos ϭ pain) is a term used to describe: ' A rare disorder of unknown aetiology characterized by intense burning extremity pain associated with erythema and increased skin temperature. Warmth intensifies the discomfort while cold provides relief ' [1] . In 1938 Smith & Allen [2] proposed a subdivision of EM into primary and secondary groups. They also introduced the term erythermalgia, emphasizing the temperature increase found in affected skin during symptomatic periods. In 1964 Babb et al. [3] published a retrospective study of 51 cases, the largest material published so far in the West. Most articles on the subject report few cases, and no information on longterm prognosis is available. The pathogenesis of EM has been subject to debate. Physiological studies have demonstrated coexistence of hypoxia and hyperaemia in affected skin [4] . On the basis of these findings and clinical observations, Kvernebo hypothesized maldistribution of skin perfusion with high levels of arterio-venous shunting resulting in increased thermoregulatory, and insufficient nutritive, perfusion.
This study presents a material of 87 cases followed for up to 11 years. New clinical aspects, epidemiological and aetiological factors as well as prognosis are emphasized.
Study population
The first case, a severely affected female patient, was referred to our vascular laboratory in 1983. For the last 16 years she had systematically cooled her feet in a bucket of iced water for up to 20 h a day, and she fulfilled the five clinical criteria of EM which are burning pain in hands and/or feet associated with increased skin temperature and erythema, symptoms are relieved by cooling and aggravated by warmth. Her extreme case was focused on by the Norwegian media, leading to more than a hundred referrals to our clinic. On the basis of questionnaires, which were returned and answered in co-operation with local doctors, patients were invited for consultation. Clinical findings and pathophysiological studies of the first 40 cases,
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together with a hypothesis of pathogenic mechanisms are published in a separate monograph [4] . This report presents a material of 87 patients, fulfilling the above-mentioned criteria. Patients were recruited continuously from 1983 to 1994. Because symptoms and signs are seen periodically in many patients, subjects with a convincing history without symptoms or findings at the time of examination were also included, in accordance with inclusion policy in previous papers [3] . Follow up of all survivors were performed during the period 1991-1994. One patient was reviewed from hospital records only.
Methods
A full medical history and physical examination were taken at the first consultation. The ankle/brachial systolic blood pressure ratio was recorded bilaterally with an ultrasound Doppler technique. Family history of EM, age, sex, age at onset of symptoms and at time of diagnosis, affected sites, development of disease severity according to an extended version of a previously introduced severity scale [4] were recorded (Table 1) .
Routine laboratory tests included haemoglobin and haematocrit, erythrocyte sedimentation rate; erythrocyte, white blood cell and thrombocyte counts; serum creatinine, urea, blood glucose, Na, K, SGOT, SGPT, rheumatoid factor, anti-nuclear antigen, anti-neutrophil cytoplasmic antibodies; urine chemical analyses for blood, glucose and protein. Bone marrow examinations were performed when considered relevant (10 patients).
Clinical classification was performed according to the classification proposed by Kvernebo [4] . The term 'syndrome' is used when initial and gradual symptoms appear in childhood or adolescence and there is a family history of EM; these patients are affected in the feet and leg skin only. The term 'phenomenon' is used for all other cases. The condition is primary when no underlying disease is known and secondary when symptoms are considered to be caused by a primary disease. Symptoms may be acute (maximum strength reached within 1 month from debut of symptoms) or chronic.
Results

Classification
About two-thirds of patients are primary cases and around three-quarters have a chronic condition (Fig. 1) .
Underlying diseases in secondary EM
A variety of primary diseases listed in Table 2 were found in patients with secondary EM.
Inheritance
Two cases, mother and daughter, are classified as erythromelalgic syndromes (ES). Over time the mother developed a severe disease (severity group 7; Table  1 ) with a need for cooling more than 12 h a day in addition to opioid analgesics. Due to repeated septic episodes caused by infected skin ulcers and druginduced agranulocytosis, bilateral amputation with disarticulation of the knee joints was carried out 9 years after her initial contact with our group. Follow-up for 24 months showed no relapse of EM in the stumps. Nine other patients (seven females and two males, six with primary chronic erythromelalgic phenomenon, one acute primary erythromelalgic phenomenon and two with secondary chronic erythromelalgic phenomenon) had mostly female relatives with a possible history of EM.
Severity and prognosis
At the time of inclusion the mean severity of primary EM was 2.3 (34 of 48 patients were asymptomatic at 
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Feeling burning pain periodically 31 Immersion in cold water Ͻ1 h day
Feeling burning pain periodically 07 Immersion in cold water 1-3 h day
Ϫ1
5
Feeling burning pain periodically 07 Immersion in cold water 3-6 h day 
6
Feeling strong burning pain 02 Immersion in cold water 6-12 h day 
7
Feeling very strong burning pain 03 Immersion in cold water Ͼ12 h day 
8
Feeling very strong burning pain continually 02 Continual need for cooling or plexus/epidural anaesthesia the time of investigation), for secondary EM 2.6 (21 of 37 patients were asymptomatic) and for ES 5.0 (both patients were symptomatic) according to the scale proposed in Table 1 . In the total material maximal severity during the follow up period was 2.94 (mean)/3 (median). There were no significant differences between the primary and secondary EM (P Ͼ 0.5 Mann-Whitney U-test).
The severity usually fluctuated during 24-h periods, but over periods of weeks and months. Seven With time the trend is that ES gradually gets worse until high severity, primary and secondary acute EM gets better, whilst primary and secondary chronic EM generally has a stable chronic course, Table 3 .
Two patients had ulcers on feet or legs. One of our patients had necrosis of two toes. His whole foot to ankle level was intensely red, oedematous and he complained of typical EM symptoms. The brachial blood pressure was 120/80 mmHg, and systolic ankle pressure was 120 mmHg. He was nondiabetic and had no fever or laboratory signs of infection or polycythemia. Radiography of the extremity showed no sign of osteomyelitis. Lower limb arteriography did not show significant arterial stenoses until the level of the necrotic digits, and ultrasound Doppler examination of the popliteal and femoral veins were normal.
Bilateral amputation at the knee joints was carried out in the female patient with ES and unilateral midcalf amputation in the male patient with primary EM who developed gangrene of the toes and intractable pain. Initially his pain and erythema improved considerably with prostaglandin E1 infusion for 72 h, but the symptoms relapsed after 2 weeks and then the patient, who was an alcoholic, refused further medical therapy and insisted upon amputation.
Age
The mean age at onset of the condition for patients with the syndrome was 11.6 years. For primary EM the age was 43.4 (7.8-76.6) years (mean with range), and for secondary cases 49.1 (18.9-81.3) years. The age at diagnosis was 23.2 for syndromes, 51.9 (8.0-81.6) years for primary cases and 54.4 (22.1-82.3) years for secondary cases. In the total material the mean time from initial debut of symptoms to diagnosis was 5.6 (0.01-46.3) years.
Location and sex
The condition is most commonly located in the lower extremities, but location in the hands is also seen (Table  4) . Of the patients with affection only of the upper limbs, three-quarters had secondary EM. Most unilateral cases were secondary EM. ES is always located in the lower extremities only and may affect leg skin as well as the whole foot. One female with chronic primary erythromelalgic phenomenon also had facial symptoms and signs. She cooled her face with cold wet cloths for up to 3 h per day and symptoms became worse in warmth. The facial symptoms fluctuated with those of the hands and feet.
For all subgroups there were more females affected than males (Table 5) .
Discussion
The present material is the largest material published in the literature of western medicine and is unique in Secondary acute erythromelalgic n ϭ 12 n ϭ 12
Data given as mean severity score (range).
the sense that all patients have been seen by two of the authors (O.M.K. and K.K.), and that all included patients over a period of up to 11 years have been followed up. The second largest material published in the West is a retrospective material from the Mayo clinic [3] , whilst reports of epidemics with thousands of cases of EM have been published from China [5] .
Inclusion
The definition of the condition has been debated [6, 7] . In a comment in the British Medical Journal in 1986 Housley states that he has not seen one convincing case over a time period of 16 years in the peripheral vascular clinic of the Royal Infirmary of Edinburgh, Scotland, UK, and therefore questions the existence of the condition [8] . This confusion may be related to the definition of inclusion criteria. In our material we have applied defined clinical criteria accepted by most authors for inclusion of patients. In our opinion erythromelalgia is not a separate disease entity but a pathophysiological response of the skin microcirculation [4] . An analogy is that inflammation is easily recognized clinically by the classical findings of tumour, rubor, calor and functio laesa. Still it is not a separate disease, but a response provoked by micro-organisms, trauma, necrosis, immune reaction or neoplasm. The present material may indicate that EM is more common than previously thought, especially in the lower severity groups where the person affected may not consider it a disease warranting a visit to the doctor, or the doctor may not recognize the condition.
However, it can be debated whether mild cases (severity groups 1 and 2) should be included as true EM or as borderline cases. They are included in this material, to emphasize the continuous spectrum of severity from trivial distress to limb-threatening disease.
In some few cases erysipelas, cellulitis or osteomyelitis were considered as differential diagnosis, but ruled out on the basis of normal ESR and white blood cell count in addition to the clinical course.
Classification
Primary EM is the largest subgroup, as in the Mayo Clinic material [3] . On further follow-up we expect some primary cases to be reclassified, since EM may precede myeloproliferative disease and connective tissue disease by several years [3] . In our material polycythemia vera occurred in two cases after 2 and 5 years follow up, and colonic cancer in one patient after 2 years. One other woman with polycythemia vera later developed erythrocyte leukaemia. We therefore recommend yearly haematology tests for cases with primary EM.
Primary conditions
In our material a wide variety of clinical conditions were associated with EM. Microvascular arteriovenous (AV) shunting has been proposed as the cause whereby these primary diseases induce EM [4] . Kvernebo claimed that shunting could be induced by opening of anatomical AV anastomosis normally located in hands, feet, nose and ears, or by angioneogenesis (erythromelalgic syndrome). A reduced functional capillary density with a thoroughfare channel mechanism was postulated in cases with an abnor- 
Heredity
Twelve patients in our material had a probable familial history of which only two were males. In no case was male to male transmission suspected. Finley et al. [9] reported a family where 27 members over five generations had EM. He observed no case of male-tomale transmission and 22 of the cases were females. An autosomal dominant mode of heredity was suspected.
Severity/prognosis
The majority of both primary and secondary EM patients were in severity groups 2 and 3. Babb found that primary EM was more severe than secondary [3] , in contrast to our material where the secondary EM group was slightly more severe. The ES subgroup is also in other reports characterized as severe [1, 10] . Primary EM patients are younger than secondary EM patients, both at age of disease onset and at the time of the first investigation. This is similar to observations by Babb [3] . The long mean time (5.6 years) from start of symptoms to diagnosis for the total material is caused by delays by patients and doctors. An obstacle for the physician is that symptoms are often intermittent and may be absent at the time of investigation.
Reports of EM patients with periods of Raynaud's phenomenon have previously been published [11, 12] . This could be a coincidental occurrence because Raynaud's phenomenon is quite common, especially amongst females, in the general population.
Location
The mother with ES was observed for more than 9 years. Her legs were affected up to 5 cm below the knee joint. The upper border did not move more proximally during the observation period. This leads us to believe that gravitational forces may be of importance in the pathophysiology of ES.
In the German literature the term erythroprosopalgia (prosopon ϭ face) has been used [13] , and it is probably synonymous with the term 'facial EM'. The face and the auricles are the only locations, in addition the hands and the feet, where the skin has numerous arterio-venous shunts. In our patient facial symptoms occurred in parallel with symptoms in hands and feet, supporting the hypothesis that opening of arterio-venous shunting may cause EM. To our knowledge no placebo-controlled study of the therapy of EM is available in the literature. Case reports imply that aspirin [14] and vasodilatation with sodium nitroprusside or prostaglandin E1 may be tried [4, 15] ; vasoconstrictor therapy and sympathectomy are probably contraindicated [4] .
Our clinical study has demonstrated the heterogeneity of erythromelalgia in terms of aetiology, severity and prognosis. EM should be considered a condition caused by a common microvascular response, microvascular arterio-venous shunting, rather than as a separate disease entity.
